Representative Kevin Hern (Republican-Oklahoma) recently sold shares of IQVIA Holdings Inc. (NYSE:IQV). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in IQVIA stock on September 8th. The trade occurred in the Representative’s “GABRIELLE ASHTYN HERN TRUST” account.
Representative Kevin Hern also recently made the following trade(s):
- Sold $15,001 – $50,000 in shares of CenterPoint Energy (NYSE:CNP) on 9/15/2026.
- Sold $1,001 – $15,000 in shares of TJX Companies (NYSE:TJX) on 9/15/2026.
- Sold $15,001 – $50,000 in shares of STERIS (NYSE:STE) on 9/15/2026.
- Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 9/15/2026.
- Sold $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 9/14/2026.
- Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of IQVIA (NYSE:IQV) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
- Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of Emerson Electric (NYSE:EMR) on 9/14/2026.
IQVIA Trading Down 0.8%
Shares of IQVIA stock traded down $2.12 on Tuesday, reaching $268.85. The company had a trading volume of 398,830 shares, compared to its average volume of 1,726,363. IQVIA Holdings Inc. has a 1 year low of $154.50 and a 1 year high of $277.40. The firm’s 50-day moving average price is $250.32 and its two-hundred day moving average price is $203.63. The firm has a market cap of $44.25 billion, a price-to-earnings ratio of 33.34, a P/E/G ratio of 2.31 and a beta of 1.18. The company has a debt-to-equity ratio of 2.18, a current ratio of 0.71 and a quick ratio of 0.71.
Analyst Ratings Changes
A number of research firms have recently commented on IQV. Robert W. Baird boosted their price objective on IQVIA from $252.00 to $287.00 and gave the company an “outperform” rating in a research report on Wednesday, July 29th. Wall Street Zen raised IQVIA from a “hold” rating to a “buy” rating in a research note on Saturday, September 12th. Weiss Ratings upgraded shares of IQVIA from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday. Truist Financial reiterated a “buy” rating and set a $329.00 target price (up from $300.00) on shares of IQVIA in a report on Monday. Finally, Stifel Nicolaus raised their target price on shares of IQVIA from $220.00 to $276.00 and gave the company a “buy” rating in a report on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $257.75.
Insider Activity at IQVIA
In other news, insider W. Richard Staub sold 5,500 shares of the firm’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $232.68, for a total transaction of $1,279,740.00. Following the completion of the sale, the insider owned 13,312 shares of the company’s stock, valued at approximately $3,097,436.16. This trade represents a 29.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Bhavik Patel sold 1,855 shares of the stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $235.27, for a total transaction of $436,425.85. Following the sale, the insider directly owned 1,348 shares in the company, valued at $317,143.96. This trade represents a 57.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 15,581 shares of company stock valued at $3,796,021. 1.70% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On IQVIA
A number of institutional investors and hedge funds have recently added to or reduced their stakes in IQV. Compass Financial Management LLC bought a new position in shares of IQVIA in the second quarter worth $27,000. Financial Freedom LLC purchased a new stake in IQVIA in the 1st quarter worth about $25,000. Ascentis Independent Advisors acquired a new position in shares of IQVIA in the first quarter worth $25,000. Elevation Wealth Partners LLC increased its stake in shares of IQVIA by 218.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 153 shares of the medical research company’s stock worth $30,000 after purchasing an additional 105 shares during the last quarter. Finally, Hilton Head Capital Partners LLC acquired a new stake in IQVIA in the 4th quarter worth approximately $35,000. 89.62% of the stock is owned by hedge funds and other institutional investors.
About Representative Hern
Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.
Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.
Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.
About IQVIA
IQVIA Holdings Inc (NYSE: IQV) is a global provider of technology, analytics and contract research services for the life sciences industry. The company helps pharmaceutical, biotechnology and medical device organizations develop products, manage clinical trials, understand healthcare markets and improve commercial performance.
IQVIA’s offerings include clinical research and trial management, real-world data and evidence, healthcare analytics, technology platforms, consulting, and commercial services such as sales support and patient engagement.
Recommended Stories
- Five stocks we like better than IQVIA
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
- Tesla’s Semi Is Finally Here—But Will It Move the Stock?
- 5 Stocks Showing Why Pricing Power Matters More Than Government Money
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.
